Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Role of 5-alpha Reductase in Mediating Testosterone Actions.

Trial Profile

The Role of 5-alpha Reductase in Mediating Testosterone Actions.

Phase of Trial: Phase IV

Latest Information Update: 07 Mar 2012

At a glance

  • Drugs Dutasteride; Leuprorelin; Testosterone enanthate
  • Indications Hypogonadism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Mar 2012 Results published in JAMA: the Journal of the American Medical Association.
    • 18 May 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
    • 18 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top